前收市價 | 2.7000 |
開市 | 2.7000 |
買盤 | 2.0000 |
賣出價 | 2.8000 |
拍板 | 2.50 |
到期日 | 2024-05-17 |
今日波幅 | 2.7000 - 2.7000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2 |
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16. PBYI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Camilla, […]
Puma Biotechnology (PBYI) reports narrower-than-expected first-quarter 2024 loss. The company maintains its revenue guidance for 2024.
On Puma Biotechnology's (PBYI) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its sole marketed cancer drug, Nerlynx.